Kun Jiang is an advisor at Future Health Asia, an angel investment group focusing on seed-stage health-tech companies in the Asia Pacific region. With the passion for utilizing technology to solve problems in healthcare, she founded Bio-Mark, a healthcare analytics company that was successfully acquired by a large healthcare organization in South East Asia in 2020.
